Signal Transduction and Targeted Therapy,
Journal Year:
2025,
Volume and Issue:
10(1)
Published: April 2, 2025
Abstract
Phototherapy
has
emerged
as
a
promising
modality
in
cancer
treatment,
garnering
considerable
attention
for
its
minimal
side
effects,
exceptional
spatial
selectivity,
and
optimal
preservation
of
normal
tissue
function.
This
innovative
approach
primarily
encompasses
three
distinct
paradigms:
Photodynamic
Therapy
(PDT),
Photothermal
(PTT),
Photoimmunotherapy
(PIT).
Each
these
modalities
exerts
antitumor
effects
through
unique
mechanisms—specifically,
the
generation
reactive
oxygen
species
(ROS),
heat,
immune
responses,
respectively.
However,
significant
challenges
impede
advancement
clinical
application
phototherapy.
These
include
inadequate
ROS
production
rates,
subpar
photothermal
conversion
efficiency,
difficulties
tumor
targeting,
unfavorable
physicochemical
properties
inherent
to
traditional
phototherapeutic
agents
(PTs).
Additionally,
hypoxic
microenvironment
typical
tumors
complicates
therapeutic
efficacy
due
limited
agent
penetration
deep-seated
lesions.
To
address
limitations,
ongoing
research
is
fervently
exploring
solutions.
The
advantages
offered
by
nano-PTs
nanocarrier
systems
aim
enhance
approaches’
effectiveness.
Strategies
such
generating
situ
within
or
inhibiting
mitochondrial
respiration
while
targeting
HIF-1α
pathway
may
alleviate
hypoxia.
Moreover,
utilizing
self-luminescent
materials,
near-infrared
excitation
sources,
non-photoactivated
sensitizers,
wireless
light
delivery
can
improve
penetration.
Furthermore,
integrating
immunoadjuvants
modulating
immunosuppressive
cell
populations
deploying
checkpoint
inhibitors
holds
promise
enhancing
immunogenic
death
PIT.
review
seeks
elucidate
fundamental
principles
biological
implications
phototherapy
discussing
dominant
mechanisms
advanced
strategies
designed
overcome
existing
challenges—ultimately
illuminating
pathways
future
aimed
at
amplifying
this
intervention’s
efficacy.
Journal of Nanobiotechnology,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: May 12, 2024
Abstract
Zinc
oxide
nanoparticles
(ZnO
NPs)
stand
as
among
the
most
significant
metal
in
trigger
formation
of
reactive
oxygen
species
(ROS)
and
induce
apoptosis.
Nevertheless,
utilization
ZnO
NPs
has
been
limited
by
shallowness
short-wavelength
light
constrained
production
ROS.
To
overcome
these
limitations,
a
strategy
involves
achieving
red
shift
towards
near-infrared
(NIR)
spectrum,
promoting
separation
restraining
recombination
electron-hole
(e
−
-h
+
)
pairs.
Herein,
hybrid
plasmonic
system
Au@ZnO
(AZ)
with
graphene
quantum
dots
(GQDs)
doping
(AZG)
nano
heterostructures
is
rationally
designed
for
optimal
NIR-driven
cancer
treatment.
Significantly,
multifold
increase
ROS
generation
can
be
achieved
through
following
creative
initiatives:
(i)
Au
nanorods
expands
photocatalytic
capabilities
AZG
into
NIR
domain,
offering
foundation
NIR-induced
clinical
utilization;
(ii)
elaborate
design
mesoporous
core-shell
AZ
structures
facilitates
redistribution
pairs;
(iii)
incorporation
GQDs
structure
could
efficiently
restrain
e
(iv)
Modification
hyaluronic
acid
(HA)
enhance
CD44
receptor
mediated
targeted
triple-negative
breast
(TNBC).
In
addition,
introduced
NRs
present
catalysts
enhancing
photothermal
therapy
(PTT),
effectively
inducing
apoptosis
tumor
cells.
The
resulting
HA-modified
(AZGH)
exhibits
efficient
hot
electron
injection
separation,
affording
unparalleled
convenience
enabling
PDT
treanment.
As
result,
our
well-designed
AZGH
photosensitizers
exhibit
excellent
efficacy.
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(9), P. 1057 - 1057
Published: Aug. 25, 2024
In
recent
decades,
immunotherapy
has
been
considered
a
promising
treatment
approach.
The
modulatable
enhancement
or
attenuation
of
the
body's
immune
response
can
effectively
suppress
tumors.
However,
challenges
persist
in
clinical
applications
due
to
lack
precision
antigen
presentation
cells,
escape
mechanisms,
and
immunotherapy-mediated
side
effects.
As
potential
delivery
system
for
drugs
immunomodulators,
mesoporous
silica
attracted
extensive
attention
recently.
Mesoporous
nanoparticles
(MSNs)
possess
high
porosity,
large
specific
surface
area,
excellent
biocompatibility,
facile
modifiability,
making
them
suitable
as
multifunctional
carriers
immunotherapy.
This
article
summarizes
latest
advancements
application
MSNs
cancer
immunotherapy,
aiming
stimulate
further
exploration
immunomodulatory
mechanisms
development
immunotherapeutics
based
on
MSNs.
Advanced Optical Materials,
Journal Year:
2024,
Volume and Issue:
12(18)
Published: March 18, 2024
Abstract
Alkaline
zirconium
fluorides
(A
x
Zr
y
F
x+y
,
A
=
Li,
Na,
and
K),
featuring
unique
crystallographic
structures,
have
recently
emerged
as
a
class
of
attractive
hosts
for
fabricating
lanthanide
(Ln
3+
)‐doped
upconversion
nanocrystals
(UCNCs)
that
exhibited
distinct
morphology,
luminescence
(UCL)
performance,
physicochemical
property.
In
this
paper,
the
first
time
controlled
preparation
Yb
/Er
‐doped
UCNCs
is
reported
based
on
trigonal
Cs
2
ZrF
6
host,
leading
to
tunable
morphology
size
resulting
by
varying
reaction
temperature
time.
By
further
incorporating
Na
+
ions
into
crystal
lattice,
sub‐10
nm
/Na
tridoped
with
highly
improved
crystallinity
thus
greatly
enhanced
UCL
intensity
are
obtained.
Moreover,
these
display
abnormal
thermal
enhancement
over
range
from
333
493
K,
enabling
fabrication
supersensitive
luminescent
nanothermometers
sensing.
Based
ratio
two
nonthermally
coupled
levels
(i.e.,
4
9/2
H
11/2
)
Er
as‐prepared
:Yb/Er/Na
exhibit
an
extremely
large
absolute
sensitivity
177.3%
K
−1
considerably
high
relative
1.52%
at
K.
These
results
unambiguously
demonstrate
suitable
host
material
preparing
small‐sized
Ln
nanothermometer
high‐performance
ratiometric
Romanian Journal of Morphology and Embryology,
Journal Year:
2024,
Volume and Issue:
65(2), P. 173 - 184
Published: July 15, 2024
Over
the
last
decades,
silica
nanoparticles
(SiNPs)
have
been
studied
for
their
applications
in
biomedicine
as
an
alternative
used
conventional
diagnostics
and
treatments.
Since
properties
can
be
modified
adjusted
desired
use,
they
many
different
potential
medicine:
diagnosis
because
of
ability
to
loaded
with
dyes
increased
selectivity
sensitivity,
which
improve
quality
diagnostic
process.
SiNPs
functionalized
by
targeting
ligands
or
molecules
detect
certain
cellular
processes
biomarkers
better
precision.
Targeted
delivery
is
another
fundamental
use
SiNPs.
They
could
drug
systems
(DDS)
since
structure
allows
loading
therapeutic
agents
other
compounds,
studies
demonstrated
biocompatibility.
When
are
DDS,
drug’s
toxicity
off-target
effects
reduced
significantly,
treat
conditions
like
cancer
neurological
diseases
even
aid
regenerative
processes,
such
wound
healing
bone
repair.
However,
safety
concerns
must
considered
before
extensively
clinical
practice
NPs
cause
accumulate
at
undesired
locations.
Therefore,
overview
that
medicine,
well
concerns,
will
covered
this
review
paper.
We
have
developed
an
innovative
Cu-doped
and
DTX-loaded
Cu-MnO2@DTX@FA
(MCDF)
nanodrug
designed
to
strategically
alter
tumor
microenvironment
(TME)
by
harnessing
the
synergistic
effects
of
chemodynamic
therapy
(CDT),
chemotherapeutic
agents,
induction
ferroptosis
cuproptosis.
The
MCDF
efficiently
degrades,
releasing
abundant
Mn4+,
Cu2+,
DTX.
conversion
Cu2+
Cu+
facilitated
FDX1
initiates
cuproptosis,
while,
similar
Mn2+,
reacts
with
hydrogen
peroxide
(H2O2)
generate
hydroxyl
radicals
(·OH).
Mn4+
oxidize
glutathione
(GSH),
significantly
depleting
GSH
levels
in
cells
inactivating
GPX4,
which
further
promotes
ferroptosis.
release
intensifies
DTX
effectively
disrupts
cell
division
cycle,
thereby
inhibiting
proliferation
spread
cells.
FA-modified
is
evade
immune
detection
while
selectively
targeting
tissues,
ensuring
precision
treatment
delivery.
This
cutting-edge
material
not
only
provides
a
multifunctional
therapeutic
strategy
but
also
sets
stage
for
next
generation
tumor-targeting
nanomedicines.
Nanomedicine,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 12
Published: Jan. 29, 2025
Photodynamic
therapy
(PDT)
involves
the
activation
of
photosensitizers
(PSs)
by
visible
laser
light
at
target
site
to
catalyze
production
reactive
oxygen
species,
resulting
in
tumor
cell
death
and
blood
vessel
closure.
The
efficacy
PDT
depends
on
PSs,
amount
oxygen,
intensity
excitation
laser.
PSs
have
been
extensively
researched,
great
efforts
made
develop
an
ideal
photosensitizer.
Chlorin-e6
is
FDA-approved
second-generation
that
has
attracted
widespread
research
interest
medical
field,
especially
with
respect
antitumor
anti-inflammatory
activity.
possesses
advantages
a
large
absorption
coefficient,
high
strength,
low
residue
body,
relatively
safety
thus
promising
application
prospects.
Here
we
review
use
chlorin-e6
discuss
prospects
further
development
this
technology.
Nanoscale,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Nanotechnology
enables
targeted
theranostics
by
enhancing
imaging
and
therapy.
This
review
explores
advances
in
pH-induced
charge-switchable
nanomaterials,
their
role
drug
delivery
contrast,
future
directions
the
field.